Title

Cocaine/Crack and Reduction of Compulsion With Biperiden
Cocaine/Crack Dependence: A Study of the Possible Reduction of Compulsion Under the Use of Biperiden
  • Phase

    Phase 3
  • Study Type

    Interventional
  • Intervention/Treatment

    biperiden ...
  • Study Participants

    111
Considering the effects of the cholinergic system on the drug reward and self-administration mechanisms, acetylcholine (Ach) may play an important role on cocaine dependence process. Then the present study aims to evaluate biperiden efficacy (a cholinergic antagonist) in attenuate compulsion, one o the main symptoms of the drug dependence.
Cocaine consumption affects around 13.4 mi people or 0.3% of the world population between 15 and 64 years old. The drug dependence has been described by many authors as a dysfunction of the brain reward system. Considering the effects of the cholinergic system on the drug reward and self-administration mechanisms, acetylcholine (Ach) may play an important role on cocaine dependence process. Then the present study aims to evaluate biperiden efficacy (a cholinergic antagonist) in attenuate compulsion, one o the main symptoms of the drug dependence. To accomplish this purpose 60 cocaine or crack male users between 18 and 50 years old will be study. This is a double-blind controlled and randomized placebo study. All the patients will be treated with brief intervention therapy (BIT), and half of them will receive biperiden (6mg/day) while the other half will receive placebo. The treatment efficacy will be evaluated through the comparison between the values obtained on the following measures before and after the treatment: Craving scale of Minnesota and Cocaine/crack consumption questionnaire, and the presence of the cocaine metabolite (benzoylecgonine) on urine.
Study Started
May 31
2011
Primary Completion
Dec 31
2011
Study Completion
Nov 30
2012
Results Posted
Feb 28
2020
Last Update
Oct 14
2020

Drug Biperiden

Thirty volunteers will take three pills of Biperiden (6mg/day) during two months.

  • Other names: Group psychotherapy

Drug Placebo

Thirty volunteers will take three pills of Placebo (6mg/day) during two months.

  • Other names: Group psychotherapy

Biperiden Experimental

Thirty volunteers will take three pills of Biperiden (6mg/day) during two months.

Placebo Placebo Comparator

Thirty volunteers will take three pills of Placebo (6mg/day) during two months.

Criteria

Inclusion Criteria:

Cocaine or crack dependence, according to the DSM-IV criteria (APA, 1994)

Exclusion Criteria:

Being under treatment with psychoactive drugs
Have been diagnosed for other Psychiatric Disorders
Have dependence diagnosis for other drugs, except for tabacco

Summary

Placebo

Biperiden

All Events

Event Type Organ System Event Term Placebo Biperiden

Compulsion

The patients answered the Minnesota Cocaine Craving Scale (Halikas et al., 1991). INTENSITY: Evaluation of crack strength by cocaine in the previous week: Zero (no craving)---------------------------- -----10 (Intense craving) Ranges from 0 to 10 (zero = no craving; 10 intense craving). Using a rule starting from 0, we determine the number that corresponds to the compulsion. The farther from 0 the more intense the compulsion will be. Frequency of craving onset: How many times a day 0 time/day - check: 0 point time/day - check: 1 point times/day - check: 2 points to 5 times/day - check: 3 points 6 to 10 times/day - check: 4 points 11 to 20 times/day - check: 5 points more than 20 times/day - check: 6 points Ranges from 0 to 6 points (zero = no craving; 1-2 points: Light; 3-4 points: moderate; 5- 6: intense craving). The sum of the points of the subscales provides the final score.

Biperiden

5.9
score on a scale (Mean)
Standard Deviation: 2.6

Placebo

5.5
score on a scale (Mean)
Standard Deviation: 2.6

Total

111
Participants

Age, Continuous

32.2
years (Mean)
Standard Deviation: 7.1

Ethnicity (NIH/OMB)

Region of Enrollment

Sex: Female, Male

Overall Study

Biperiden

Placebo